Inhibition of melanogenesis by tyrosinase inhibitors sensitized melanoma cells towards cytotoxic action of chemotherapeutic agents or immunotoxic activities of IL-2 activated lymphocytes [43]. This evidence concerns the gene TYR and melanoma.